HIV Cure
Nancy Archin, PhD, Assistant Professor, Infectious Diseases
Loading view.
Institute for Global Health & Infectious Diseases
Events from this organizer
From HIV to COVID and Back: COVID-19 Vaccines in People Living With HIV
Nigel Garrett, MBBS, MRCP, MSc, PhD, Honorary Associate Professor in Public Health at the University of KwaZulu-Natal, and head of HIV Pathogenesis and Vaccine Research for Center for the AIDS Programme of Research in South Africa (CAPRISA).
Pharmacological Evaluation of Long-Acting Formulations for HIV and TB
Andrew Owen, BSS, MSc, PhD, FSB, Professor of Molecular and Clinical Pharmacology at the University of Liverpool, UK, and Director of the Centre of Excellence in Long-acting Therapeutics (CELT).
Reconceptualizing Antibiotic Therapy Taking Host-Pathogen Interaction into Consideration
Gauri Rao, Pharm.D., M.S., is an associate professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics.
The One Health Approach to AMR
Sid Thakur, BVSc, MVSc, PhD, Professor of Molecular Epidemiology, Director of Global Health, NC State College of Veterinary Medicine.
STI/HIV Research Presentations
T32 trainees will present STI/HIV research presentations.
Bacteriophage Therapy: Is it a Feasible Approach for Treating Intracellular Nontuberculous Mycobacteria?
Miriam Braunstein, PhD, Professor of Microbiology and Immunology, member of the Institute for Global Health & Infectious Diseases
HIV Persistence
Mary F. Kearney, PhD, HIV Dynamics and Replication Program, NIH Cancer Center
Mechanisms of β-lactam Resistance
Robert Bonomo, MD, professor of medicine, pharmacology, molecular biology and microbiology, Case Western School of Medicine.
Host-Pathogen Dynamics
Nihal Altan-Bonn, PhD, Senior Investigator, NIH Laboratory of Host-Pathogen Dynamics
Building a Fasciola Hepatica Research Program in the Highlands of Peru
Miguel M. Cabada, MD, MSc, Associate Professor at the Division of Infectious Diseases of University of Texas Medical Branch
A Community-Led Model to Improve PrEP Uptake and HBV/HCV Testing Among MSM in China
Weiming Tang, PhD, Research Associate Professor and Co-Director of UNC Project-China with the Institute for Global Health & Infectious Diseases
5th Annual Malawi Cancer Symposium
The 5th Annual Malawi Cancer Symposium is a collaboration between the UNC Institute for Global Health and Infectious Diseases and UNC Lineberger Comprehensive Cancer Center. For more information, please contact ggomani@unclilongwe.org.
Q&A Session: Fogarty Global Health LAUNCH
Whether you're just starting or further along in your academic journey, the Fogarty Global Health LAUNCH program could be your next big step in making a global impact. Don't miss this opportunity to get your questions answered and set yourself on a path towards meaningful global health research. Question & Answer Session: Date: October 5, … Read more
Translating Cabotegravir PrEP From Clinical Trials to the Field: Upcoming Malawi Plans
Mina Hosseinipour, MD, MPH, is a professor of medicine and the scientific director of UNC Project-Malawi. She focuses on the management of HIV disease in developing countries including prevention, interactions with endemic diseases, treatment of opportunistic infections including malignancies and monitoring strategies for antiretroviral therapy in this setting. The evaluation of the use of antiretroviral … Read more
Tracking the Gut Microbial Ecosystem in Cancer: My Adventures in Microbiome Science
Tessa M. Andermann, MD, MPH, is focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations.
Emergence of Diagnostic-Resistant Malaria in Africa
Jonathan Parr, MD, MPH, is an assistant professor of medicine who studies the molecular epidemiology of infectious diseases. He is broadly interested in applying cutting-edge molecular and genomic tools to solve problems faced by marginalized populations across the globe. His work has focused on malaria in the Democratic Republic of the Congo and other sites, … Read more
Tickborne Illnesses
Rafael Felipe Da Costa Vieira, PhD, is an assistant professor of One Health in the Department of Public Health Sciences and CIPHER at UNC-Charlotte. Dr. Vieira's research focuses on the ecoepidemiology of ticks and tick-borne diseases (TBD), genetic diversity of TBD pathogens, tick microbiome, pathogen discovery, and One Health. Over the last 12 years, his … Read more
Richard Reithinger, PhD, MSc
Richard Reithinger, PhD, MSc, a distinguished fellow with the Research Triangle Institute, is a practical, innovative leader and extensively published author in the field of malaria and other vector-borne disease epidemiology, case management, prevention, and control. He is an epidemiologist with extensive field-based experience managing infectious disease programs in Africa, Central Asia, and Latin America, … Read more
The Carolina Survivor Clinic: Using Primary Care to Treat Refugees who are Torture Survivors
Rajeev K. Bais, MD, is an Assistant Professor in the Division of Infectious Diseases at the University of South Carolina School of Medicine. He is the founder and director of the Carolina Survivor Clinic, providing comprehensive care to refugees who are survivors of torture. Dr. Bais is developing a Global Health and Human Rights Initiative in the Division of Infectious … Read more